We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current DRMAW market cap is 53.89k. The company's latest EPS is USD -2.4443 and P/E is -1.73.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -1.71M | -2.28M | -1.73M | -1.81M | -2.22M |
Net Income | -1.67M | -2.24M | -1.7M | -1.72M | -2.13M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 |
Operating Income | -3.17M | -7.86M | -9.67M | -8.04M |
Net Income | -3.24M | -7.9M | -9.61M | -7.8M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Assets | 6.94M | 9.3M | 8.71M | 7.32M | 7.98M |
Total Liabilities | 922k | 1.21M | 683k | 916k | 1.62M |
Total Equity | 6.02M | 8.09M | 8.03M | 6.41M | 6.36M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 605k | 11.62M | 6.94M | 7.98M |
Total Liabilities | 3.78M | 1.52M | 922k | 1.62M |
Total Equity | -3.18M | 10.11M | 6.02M | 6.36M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Operating | -8.83M | -1.65M | -3.49M | -5.26M | -6.41M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 4.28M | 4.18M | 5.69M | 5.65M | 7.61M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -4.03M | -5.69M | -8.83M | -6.41M |
Investing | N/A | N/A | N/A | N/A |
Financing | 2.57M | 15.96M | 4.28M | 7.61M |
Market Cap | 53.89k |
Price to Earnings Ratio | -1.73 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.81 |
Price to Book Ratio | 2.12 |
Dividend Yield | - |
Shares Outstanding | 3.19M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.01 (70.41%) |
Company Name | Dermata Therapeutics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.dermatarx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions